Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03496922 · ClinicalTrials.gov registry record · NA

Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7

A NA study of Cigarette Smoking, sponsored by Virginia Polytechnic Institute and State University.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03496922 is a NA study of Cigarette Smoking that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 9 participants, below the 176-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03496922, a NA study of Cigarette Smoking, has completed, sponsored by Virginia Polytechnic Institute and State University.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

Participants will be given the opportunity to purchase ventilated, unventilated, and alternative nicotine products at different prices using an account balance based on their typical, daily nicotine product purchasing. Additionally, account balances will differ across trials.

Conditions Studied

Interventions

  • BEHAVIORAL Experimental Tobacco Marketplace

Study Locations (1)

Virginia

  • Fralin Biomedical Research Institute at VTC - Roanoke

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-04-30
Est. Completion 2018-06-15
Phase NA

What the Registry Record Tells You About NCT03496922

The ClinicalTrials.gov registry entry for NCT03496922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (95% lower). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarette Smoking appearing as the primary indexed condition, and to 1 intervention - of which Experimental Tobacco Marketplace is the first listed.

NCT03496922 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03496922 about?

NCT03496922 is a clinical study titled "Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7". Participants will be given the opportunity to purchase ventilated, unventilated, and alternative nicotine products at different prices using an account balance based on their typical, daily nicotine product purchasing. Additionally, account balances will differ across trials.

What is the current status of trial NCT03496922?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-04-30. Estimated completion is 2018-06-15.

What conditions does trial NCT03496922 study?

This clinical trial studies the following conditions: Cigarette Smoking.

What interventions are being tested in trial NCT03496922?

The interventions under investigation include: Experimental Tobacco Marketplace (BEHAVIORAL).

Who is sponsoring clinical trial NCT03496922?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03496922 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.